학술논문

Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward
Document Type
article
Source
Clinical Infectious Diseases. 71(8)
Subject
Rare Diseases
Tuberculosis
Infectious Diseases
4.2 Evaluation of markers and technologies
Detection
screening and diagnosis
Good Health and Well Being
Diagnostic Tests
Routine
Humans
Molecular Diagnostic Techniques
Mycobacterium tuberculosis
Sensitivity and Specificity
Tuberculosis
Meningeal
Tuberculous Meningitis International Research Consortium
Ultra
Xpert
cerebrospinal fluid
diagnosis
tuberculous meningitis
Biological Sciences
Medical and Health Sciences
Microbiology
Language
Abstract
The delayed diagnosis of tuberculous meningitis (TBM) leads to poor outcomes, yet the current diagnostic methods for identifying Mycobacterium tuberculosis in cerebrospinal fluid (CSF) are inadequate. The first comparative study of the new GeneXpert MTB/RIF Ultra (Xpert Ultra) for TBM diagnosis suggested increased sensitivity of Xpert Ultra. Two subsequent studies have shown Xpert Ultra has improved sensitivity, but has insufficient negative predictive value to exclude TBM. Collecting and processing large volumes of CSF for mycobacterial testing are important for optimal diagnostic test performance. But clinical, radiological, and laboratory parameters remain essential for TBM diagnosis and empiric therapy is often needed. We therefore caution against the use of Xpert Ultra as a single diagnostic test for TBM; it cannot be used to "rule out" TBM.